| Trial ID: | L7078 |
| Source ID: | NCT05086445
|
| Associated Drug: |
Ly3502970
|
| Title: |
A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: LY3502970|DRUG: Placebo
|
| Outcome Measures: |
Primary: Number of Participants with One or More Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration, A summary of TEAEs, SAEs and other non-serious adverse events (AEs), regardless of causality, will be reported in the Reported Adverse Events module, Baseline through Week 15 | Secondary: Pharmacokinetics (PK): Maximum Concentration (Cmax) of LY3502970, PK: Cmax of LY3502970, Predose on Day 1 through up to Day 88|PK: Area Under the Concentration Versus Time Curve (AUC) of LY3502970, PK: AUC of LY3502970, Predose on Day 1 through up to Day 88|Change from Baseline in Fasting Glucose, Change from Baseline in Fasting Glucose, Baseline through Day 85|Change from Baseline in Glycated Hemoglobin (HbA1c), Change from Baseline in HbA1c, Baseline through Day 85|Change from Baseline in Body Weight, Change from Baseline in Body Weight, Baseline through Day 88
|
| Sponsor/Collaborators: |
Sponsor: Eli Lilly and Company
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
62
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2021-11-12
|
| Completion Date: |
2022-09-05
|
| Results First Posted: |
|
| Last Update Posted: |
2022-11-28
|
| Locations: |
Medical Corporation Heishinkai OPHAC Hospital, Osaka-shi, Osaka, 532-0003, Japan|P-One Clinic, Hachioji, Tokyo, 192-0071, Japan|Clinical Research Hospital Tokyo, Shinjuku-ku, Tokyo, 162-0053, Japan|Medical Corporation Houeikai Sekino Clinical Pharmacology Clinic, Toshima, Tokyo, 171-0014, Japan|Yokohama Minoru Clinic, Yokohama, 232-0064, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT05086445
|
